Contact Us | Useful Links | FAQs | Feedback | Sitemap |
Holdipharma Delegation gave a visit to the newdigging site of the Suez Canal :: Holdipharma welcomes the establishment of a production facility dedicated for production of raw materials :: Egyptian Exchange "Rings the Bell For Gender Equality " :: UNGC principles with holdipharma :: New chairman of Drug Holding Co. :: The Minister of the Business Sector is following up implementation plan :: Minister of Business Sector approved the estimated "DHC budget " 2017/2018 :: President Al Sisi directs the follow-up plans to develop public sector companies :: Minister of Business Sector receives Indian Ambassador :: Drug Holding Company: “Development Committee "ends the study of the Co. structure :: Ministry Of Public Business Sector: completion of the General Assemblies of DHCs :: Minister of Business Sector assigns 3 new members of Board of Directors of the DHC :: Chairman of Drug Holding Company: 11% is our share in the Egyptian drug market :: Captain Mohammed Wanees, one of the heroes of the glorious October War :: Minister of Business Sector: Restructuring the investment portfolio of the companies :: Appointment of a new President of the Drug Holding Company :: Hisham Anwar Tawfiq, Minister of Public Business sector, replacing Khaled Badawi . :: An integrated strategy for the advancement of the Drug Holding Company :: Dr.Ahmed Hegazy Chairman of Holdipharma Company confirm that Holdipharma reaffirms its support for the ten principles of the United Nations Global Compact ::
Company Details
Company Name   Website
Chemical Industries Development(CID)

Chemical Industries Development (CID) Company was established in April 1947. It was built at Al- haram  area next to the Sphinx and the three pyramids , this location was typically assuring the continuity of the Egyptians giving throughout all ages and describes how much the greatness of Egypt by tying our bright present with our great ancient history.

CID Co. continuously adds to its records of challenge, to prove its importance as one of  the first companies that  knocked on the Upper Egypt by establishing its second Facility in Assiut in December 1962 over an area about 14 acres, in order to meet the increasing demands of medicines in the upper Egypt and to be the practical school by training the students of the Faculty of Pharmacy in Assiut University, where scientific research should be applied with work experience, so this factory became like a citadel of science and training in addition to being the first and largest National pharmaceutical facility in the Upper Egypt, now it is currently under renovation in accordance to the requirements of the Ministry of Health to increase its production capacity and to be complying with current GMP.

The company is the leading one responsible for providing the needs of MOH in Egypt, as it is obligated to participate in the national projects adopted by the Egyptian MOH, including the project for Mother and Child Health, project for preventing dehydration and diarrhea in newborns, and project of family planning.

The company is also unique for having the largest and most modern facility for the production of effervescent tablets with the latest international technologies, also unique for having a dedicated sterile zone for production of male and female sex Hormones in different types and forms for example: water and oily ampoules, in addition to the presence of the largest fully sophisticated line for the production of syrups and suspensions.

Many multinational pharmaceutical companies granted CID Co. with great confidence by manufacturing their products under license in CID. Besides, the company is considered as one of the leading Egyptian pharmaceutical companies in the field of exportation as its products are already marketed within more than 40 Arabian, African and Asian countries.

Board Members

Dr/  Mahmoud Amru Abd Alhamid Gad             Chairman of the Board 

 Dr/ Fathi Ebrahim Abd Ullah                              Non-Executive Member

Mr/ Sherif Hassan Saeed                           Non-Executive Member

Mr/ Ashraf Ahmed Salem                     Elected Member

Eng/ Abdel Samad Abdel Kareem            Elected Member


Audit Committee

Mr/ Sherif Hassan Saeed                   Non Executive Member           Chairman

     Mr/ Naser Sobhi Hafez                      Legal Affairs Advisor in Holdipharma

Mr/ Mohamed Hamza Ali                   Member

Company Main Indicators (in thousands of Egyptian Pounds)

Indicator 2015-2016 2016-2017 2017-2018
Net Operating Revenue 425678 470553 602753
Interest Expenses 0 0 0
Net Income 15916 28319 41214
Net Equity 229649 243450 251194
Working Capital 153480 159512 171352
Total Investment 261844 515116 586235
Salaries 144566 157132 176233
Number of workers 2994 2876 2734
Image Gallery
Related Links
Joint Venture
  Copyright © 2009 HOLDIPHARMA. All rights reserved.         Terms of Use | Privacy Statement | Disclaimer |